Indeed, two previous investigations have posited NUDT1 as a universal target for cancer therapies based on the observations that knockdown of NUDT1 expression or small chemical inhibition of its activity selectively induced tumor cell death without affecting normal cells20,29. The gene discussed is NUDT1; the disease is neoplasm.